Heart-Lung machine may shield High-Risk patients during valve procedure

NCT ID NCT07309029

Recruiting now Disease control Sponsor: Atlantic Health System Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using a heart-lung machine (ECMO) before a high-risk aortic valve replacement can prevent death, cardiac arrest, or emergency surgery. It includes 30 adults with severe aortic stenosis who are unstable or have complex anatomy. Participants receive ECMO support during the procedure and are followed for one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis cardiogenic shock Shock, Cardiogenic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOGENIC SHOCK CARDIOGENIC SHOCK, ECMO SEVERE AORTIC STENOSIS TRANS-CATHETER AORTIC VALVE IMPLANTATION

Contacts and locations

Locations

Center for Structural Heart Disease Henry Ford Hospital
RECRUITING

Detroit, Michigan, 48202, United States
Valve and Structural Heart Center Morristown Medical Center
RECRUITING

Morristown, New Jersey, 07960, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.